Niva Bupa Health Insurance Company Ltd
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
- Market Cap ₹ 14,601 Cr.
- Current Price ₹ 79.1
- High / Low ₹ 109 / 61.0
- Stock P/E 104
- Book Value ₹ 0.00
- Dividend Yield 0.00 %
- ROCE 7.45 %
- ROE 8.18 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 40.1% CAGR over last 5 years
Cons
- Promoter holding has decreased over last quarter: -0.55%
- Company has a low return on equity of 6.41% over last 3 years.
- Earnings include an other income of Rs.72.5 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance General Insurance
Part of Nifty 500 BSE SmallCap BSE IPO BSE Allcap BSE Financial Services
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 851 | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 5,621 | |
| 880 | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,296 | 5,553 | |
| Operating Profit | -29 | -37 | -22 | -451 | -330 | -113 | 78 | 68 |
| OPM % | -3% | -3% | -2% | -24% | -12% | -3% | 1% | 1% |
| 0 | 0 | 0 | 281 | 374 | 224 | 160 | 72 | |
| Interest | 3 | 4 | 6 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | 0 |
| Profit before tax | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 141 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| -48 | -62 | -50 | -197 | 13 | 82 | 214 | 141 | |
| EPS in Rs | 1.17 | |||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 42% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 45% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 6% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1,231 |
| 0 | 0 | 0 | 250 | 250 | 250 | 250 | |
| 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 6,452 | |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 |
| 30 | 39 | 46 | 49 | 52 | 58 | 66 | |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 |
| 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | 1,654 | |||
| -374 | -723 | -829 | -1,882 | -2,348 | |||
| 280 | 374 | 280 | 1,110 | 771 | |||
| Net Cash Flow | 164 | -12 | 43 | 41 | 78 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 |
| ROCE % | -19% | -10% | -30% | 1% | 5% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
5 Aug - Transcript of the Earnings call conducted on July 31, 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Aug - Submission of Newspaper Publication-Unaudited Financial Results for the quarter ended June 30, 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Aug - Newspaper Advertisement of Notice of 17th Annual General Meeting and information on e-voting
-
Grant Of Stock Options
1 Aug - Grant of 270,000 ESOPs under ESOP Scheme 2024 approved by Nomination & Remuneration Committee.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
31 Jul - Earnings call audio for Q1 FY2026 unaudited results available on company website.
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.